Compare PGIM India Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹1000
₹100
Expense Ratio
2.47
2.1
NAV
₹10.96
₹41.55
Fund Started
19 Nov 2024
25 Jun 2018
Fund Size
₹95.49 Cr
₹6453.52 Cr
Exit Load
Exit load of 0.50%, if redeemed within 90 days.
Exit load of 1% if redeemed within 15 days.
1 Year
11.50%
5.40%
3 Year
-
26.73%
5 Year
-
15.16%
Equity
97.89%
99.82%
Cash
0.20%
0.18%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 11.34% |
Divi's Laboratories Ltd. | 10.01% |
JB Chemicals & Pharmaceuticals Ltd. | 6.53% |
Aster DM Healthcare Ltd. | 6.44% |
Rubicon Research Ltd. | 5.97% |
Mankind Pharma Ltd. | 5.24% |
Max Healthcare Institute Ltd. | 4.97% |
Ajanta Pharma Ltd. | 4.68% |
Krishna Institute of Medical Sciences Ltd | 4.15% |
Dr. Lal Pathlabs Ltd. | 3.27% |
Sun Pharmaceutical Industries Ltd. | 12.09% |
Dr. Reddy's Laboratories Ltd. | 7.70% |
Cipla Ltd. | 7.45% |
Mankind Pharma Ltd. | 7.03% |
Divi's Laboratories Ltd. | 6.06% |
Biocon Ltd. | 4.71% |
Cohance Lifesciences Ltd. | 4.37% |
Alkem Laboratories Ltd. | 4.08% |
Medplus Health Services Ltd. | 3.86% |
Max Healthcare Institute Ltd. | 3.36% |
Name
-
-
Start Date
-
-
Description
The scheme seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
19 Nov 2024
25 Jun 2018
